Aesculap entered into an international cooperation agreement with Bio-Gate for the antimicrobial coating of revision implants for knee and hip systems. The agreement also includes an option to use HyProtect™ coating technology in other applications.
HyProtect is an ultrathin plasma coating designed to protect the surfaces of implants against bacterial colonization. It is a combination layer comprising pure silver and polysiloxane.
The basis for this cooperation was the successful completion of a preliminary development project to apply HyProtect on Aesculap implants. After completion of regulatory approvals, Bio-Gate will coat Aesculap’s implants.
To date, over 60 single patient human cases have been successfully completed, validating the high antimicrobial effectiveness and quality of Bio-Gate’s coating. The implants were primarily used in orthopedic revision surgeries for patients with a high risk of infection. In all cases to date, the patients have remained free of infection. Further clinical studies are planned.
Aesculap entered into an international cooperation agreement with Bio-Gate for the antimicrobial coating of revision implants for knee and hip systems. The agreement also includes an option to use HyProtect™ coating technology in other applications.
HyProtect is an ultrathin plasma coating designed to protect the surfaces of implants against...
Aesculap entered into an international cooperation agreement with Bio-Gate for the antimicrobial coating of revision implants for knee and hip systems. The agreement also includes an option to use HyProtect™ coating technology in other applications.
HyProtect is an ultrathin plasma coating designed to protect the surfaces of implants against bacterial colonization. It is a combination layer comprising pure silver and polysiloxane.
The basis for this cooperation was the successful completion of a preliminary development project to apply HyProtect on Aesculap implants. After completion of regulatory approvals, Bio-Gate will coat Aesculap’s implants.
To date, over 60 single patient human cases have been successfully completed, validating the high antimicrobial effectiveness and quality of Bio-Gate’s coating. The implants were primarily used in orthopedic revision surgeries for patients with a high risk of infection. In all cases to date, the patients have remained free of infection. Further clinical studies are planned.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
